Skip to content

Nasal intermittent positive ventilation (NIPPV) or conventional mechanical ventilation for neonatal respiratory failure

Nasal intermittent positive ventilation (NIPPV) or conventional mechanical ventilation for treatment of neonatal respiratory failure

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013011412132N1
Enrollment
50
Registered
2013-03-24
Start date
2012-11-28
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory failure of newborns. Respiratory failure of newborns

Interventions

Intervention 1: Nasal intermittent positive pressure ventilation (NIPPV) involves giving continuous positive airway pressure (CPAP) to the infant in the intermittent mandatory ventilation (IMV) mode.
Treatment - Devices
Nasal intermittent positive pressure ventilation (NIPPV) involves giving continuous positive airway pressure (CPAP) to the infant in the intermittent mandatory ventilation (IMV) mode.
Conventional mechanical ventilation is a methode of ventilation that paitient have endotheracheal intubation and and connect to ventilator by that.

Sponsors

Isfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: getational age less than 35 weeks; birth weight less than 2500 grams; CPAP failure (Fio2 more than 60% and maximum CPAP 8 cmH2O and/or PH less than 7.2 and PCO2 more than 60 and/or more than 3 episodes apnea with bradicardia (heart rate less than 80 per minute in 20,31,35 hours). exclusion criteria: nasopharyngeal pathology; coanal atresia; cleft/lip palate; major anomalies especially thorasic or cardiac anomalies; intra ventricular hemorrhage (IVH) grade 3 or 4 on admission; their parents refuse to participate in the research project.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Response to treatment. Timepoint: during hospitalization and using NIPPV and conventional mechanical ventilation. Method of measurement: comparing survival rates according to serial arterial blood gass (ABG) sampling.

Secondary

MeasureTime frame
Incidence of bronchopulmonary dysplasia (BPD). Timepoint: during hospitalization and using NIPPV and conventional mechanical ventilation. Method of measurement: Taking CXR on addmission and weaning.;Incidence of intra ventricular hemorrhage (IVH). Timepoint: during hospitalization and using NIPPV and conventional mechanical ventilation. Method of measurement: cranial ultrasonography on addmission and deterioration of clinical statys.;Incidence of patient dactus arteriosus (PDA). Timepoint: during hospitalization and using NIPPV and conventional mechanical ventilation. Method of measurement: Echocardiography on addmission and deterioration of clinical status.;Incidence of necrotizing enterocolitis (NEC). Timepoint: during hospitalization and using NIPPV and conventional mechanical ventilation. Method of measurement: According to Bell's criteria.;Incidence of pneumothorax. Timepoint: during hospitalization and using NIPPV and conventional mechanical ventilation. Method of measurement: Taking CXR on addmission and deterioration on clinical status.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBabak Nekooie

Isfahan University of Medical Sciences

b_nekooie@resident.mui.ac.ir+98 31 1625 5555

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026